Keyphrases
Adult Recipients
11%
Antithymocyte Globulin
100%
Cadaveric
11%
Clinical Outcomes
22%
Commercially Available
11%
Economic Outcomes
11%
Extended Criteria Donor
11%
Graft Survival
22%
Hospital Costs
11%
Hospital Stay
11%
Immunosuppressive Therapy
11%
Induction Therapy
100%
Muromonab-CD3
100%
OKT3
11%
Outcome Costs
11%
Overall Cost
11%
Pharmacoeconomics
100%
Prescribed Dose
11%
Readmission
11%
Rejection Episodes
11%
Renal Allograft
11%
Renal Allograft Transplantation
11%
Renal Transplant Recipients
100%
Serum Creatinine Level
11%
Severe Adverse Effects
11%
Transplant Center
11%
Transplantation
33%
Medicine and Dentistry
Adverse Event
11%
Allotransplantation
11%
Creatinine
11%
Graft Survival
22%
Health Care Cost
33%
Immunosuppressive Treatment
11%
Kidney Allograft
22%
Kidney Graft
100%
OKT 3
100%
Retrospective Study
11%
Thymocyte Antibody
100%
Transplantation
22%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Creatinine
11%
Immunosuppressive Agent
11%
OKT 3
100%
Pharmacoeconomics
100%
Retrospective Study
11%
Thymocyte Antibody
100%
Immunology and Microbiology
Allotransplantation
11%
Allotransplantation
11%
Anti-Thymocyte Globulin
100%
Creatinine Blood Level
11%
Immunosuppressive Therapy
11%
Muromonab-CD3
100%
Transplant Procedure
100%